The University of Nebraska Board of Regents has announced a major restructuring of the Nebraska Medicine Board of Directors in response to ongoing legal disputes and governance concerns.This decision comes as the Regents pursue an $800 million acquisition of Nebraska Medicine, which includes the buyout of Clarkson Regional Health Services' shares in the nonprofit medical provider.
Source:
nebraskaexaminer.comThe Board of Regents has replaced nearly all members of the Nebraska Medicine Board, leaving only interim UNMC Chancellor Dele Davies as a holdover from the previous group.The changes were prompted by what the Regents described as "serious concerns about recent actions and behaviors" from the Nebraska Medicine Board, particularly relating to a lawsuit filed against the Regents and Clarkson to block the acquisition deal.
Sources:
ketv.comnebraskaexaminer.comThis legal action was characterized as an "extraordinary step" by the Nebraska Medicine Board, which claimed it was necessary to protect the organization's mission and fiduciary responsibilities.The lawsuit argues that the proposed acquisition at $800 million is overvalued and violates existing lease terms by preventing Nebraska Medicine's subsidiary from exercising its rights related to Clarkson-owned properties.
Sources:
klkntv.comwowt.comIn their announcement, the Regents highlighted the need for this restructuring to safeguard the organization's "reputation, stability, and future." The new board composition includes Dr Jeffrey Gold, President of the University of Nebraska; Dr Dele Davies, the new chair of the interim board; Dr William Lydiatt, CEO of Clarkson Regional Health Services; and Stephanie Moline, a current Clarkson board member.This interim board is expected to remain in place until the deal is finalized, targeted for completion by June 30, 2023.
Sources:
nebraskaexaminer.comwowt.comThe restructuring has drawn criticism from various stakeholders, including state lawmakers and former Nebraska Medicine leaders.State Senator Brad von Gillern expressed disappointment, describing the board's dismissal as a "nuclear option" that could exacerbate tensions rather than foster communication between the Nebraska Medicine and the Regents.
Sources:
ketv.comnebraskaexaminer.comConcerns have been raised regarding the implications of this restructuring for Nebraska's philanthropic community, as many board members were significant donors and community leaders in Omaha.Senator Tony Sorrentino has proposed legislative measures that would require state approval for large transactions involving state-funded hospitals, indicating that this situation may prompt further legislative scrutiny and action.
Sources:
ketv.comnebraskaexaminer.comklkntv.comDespite the upheaval, the Regents and Clarkson have expressed optimism about the acquisition's potential to streamline operations and enhance the quality of care provided by Nebraska Medicine.They assured that day-to-day management and service delivery would remain unchanged following the transaction, which aims to improve the alignment between Nebraska Medicine and the University of Nebraska Medical Center (UNMC).
Sources:
nebraskaexaminer.comklkntv.comAs the situation continues to unfold, the Nebraska Attorney General's Office has initiated a review of the allegations surrounding the Nebraska Medicine Board and the legitimacy of the lawsuit.The outcomes of this review could significantly influence the future governance and operational structure of Nebraska Medicine.
Sources:
nebraskaexaminer.comwowt.comThe Board of Regents and Clarkson maintain that the restructuring is a necessary step to ensure that Nebraska Medicine can effectively fulfill its charitable mission and maintain its standing as a critical health care provider in the state.However, the ongoing legal challenges and reactions from various stakeholders signal that the path forward will likely remain contentious and closely monitored by the public and lawmakers alike.
